SAM PARS EXIR (SPE)

SAM PARS EXIR (SPE)

Biotechnology-Research

Industry Category
Biotechnology-Research
Company Description

SAM PARS EXIR (SPE) is a leading force in Biotechnology Research, dedicated to advancing scientific discovery and innovation. With a strong commitment to pushing the boundaries of knowledge, SAM PARS EXIR (SPE) focuses on developing cutting-edge solutions that address critical challenges in various fields. The company’s work spans a wide range of biotechnological applications, contributing to advancements that have a global impact.

SAM PARS EXIR (SPE) prides itself on a culture of excellence and collaboration. Its team of highly skilled researchers and scientists work together to explore new frontiers and develop innovative technologies. The company is dedicated to maintaining the highest standards of quality and integrity in all its research endeavors, ensuring that its contributions are both reliable and impactful. SAM PARS EXIR (SPE) is committed to driving progress and shaping the future of biotechnology.

SAM PARS EXIR (SPE)’s dedication to innovation and scientific advancement positions it as a key player in the Biotechnology Research sector. The company continues to expand its research capabilities and explore new opportunities for growth and development. We invite the manager of SAM PARS EXIR (SPE) to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.

Key Personnel / Employees
katy Hashiri (CEO Samparsexir) Samira Najjarlou (Accountant & Tour Guide)

Similar Companies

Other organizations in the same industry

QART Medical
Biotechnology-Research

A first-in-class, real-time 3D imaging system providing a quantitative topographic map of the sperm...

DiNAQOR
Biotechnology-Research

Accelerating development of early-stage advanced therapies.

Schlieren, Zurich
Switzerland
PharmaBiome AG
Biotechnology-Research

Pioneering the development of microbiome-based therapies using proprietary tools for their design an...

Proteomedix AG
Biotechnology-Research

next generation blood test for prostate cancer

Alternative Company Names

This company is also known as

SAM PARS EXIR (SPE) 萨姆·帕尔斯·埃克西尔 (SPE) सैम पार्स एक्सिर (SPE) سام بارس إكسير (SPE) САМ ПАРС ЭКСИР (SPE)